Hypothyroidism and chronic obstructive pulmonary disease

Main Article Content

Mariia Sukholytka

Abstract

The risk of chronic obstructive pulmonary disease (COPD), as well as thyroid diseases increases with age. COPD is a common systemic disease associated with chronic inflammation. Many endocrinological disorders, including thyroid gland diseases are related to systemic inflammation. Epidemiological studies suggest that patients with COPD are at higher risk of thyroid disorders. These associations are not well-studied and thyroid gland diseases are not included on the broadly acknowledged list of COPD comorbidities. They may seriously handicap quality of life of COPD patients. Unfortunately, the diagnosis may be difficult, as many signs are masked by the symptoms of the index disease. The comprehension of the correlation between thyroid gland disorders and COPD may contribute to better care of patients. In this review, we attempt to revise available literature describing existing links between COPD and thyroid diseases. The signs or symptoms of thyroid disorders may be non-specific, especially among the elderly, therefore the differential diagnosis between symptoms of COPD and symptoms related to thyroid disease can cause difficulties. Many data show higher risk of thyroid hormones alterations in COPD patients. Hypothyroidism may influence respiration by different mechanisms, even in subjects with intact respiratory system. Therefore, it is hard to distinguish whether hormonal changes are the reason or a consequence of different respiratory signs and symptoms. In some instances, the correction of hormonal alternations may improve the qua­lity of life of COPD patients and other disease outcomes. The comprehension of an association between COPD, thyroid gland function and thyroid disorders may provide important information about the systemic nature of COPD.

Article Details

How to Cite
Sukholytka, M. “Hypothyroidism and Chronic Obstructive Pulmonary Disease”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 16, no. 8, Aug. 2021, pp. 643-7, doi:10.22141/2224-0721.16.8.2020.222884.
Section
Literature Review

References

Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019 May 18;53(5):1900164. doi:10.1183/13993003.00164-2019.

Terzano C, Romani S, Paone G, Conti V, Oriolo F. COPD and thyroid dysfunctions. Lung. 2014 Feb;192(1):103-9. doi:10.1007/s00408-013-9537-6.

Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003 Nov;46:5s-13s. doi:10.1183/09031936.03.00004603a.

Agustí A, Edwards LD, Rennard SI, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012;7(5):e37483. doi:10.1371/journal.pone.0037483.

van der Molen T. Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. Prim Care Respir J. 2010 Dec;19(4):326-34. doi:10.4104/pcrj.2010.00053.

García-Olmos L, Alberquilla A, Ayala V, et al. Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study. BMC Fam Pract. 2013 Jan 16;14:11. doi:10.1186/1471-2296-14-11.

Doehner W, Haeusler KG, Endres M, Anker SD, MacNee W, Lainscak M. Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease. Respir Med. 2011 Oct;105 Suppl 1:S12-9. doi:10.1016/S0954-6111(11)70005-1.

Padmanabhan H. Amiodarone and thyroid dysfunction. South Med J. 2010 Sep;103(9):922-30. doi:10.1097/SMJ.0b013e3181e90500.

Bocchetta A, Loviselli A. Lithium treatment and thyroid abnormalities. Clin Pract Epidemiol Ment Health. 2006 Sep 12;2:23. doi:10.1186/1745-0179-2-23.

Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-Induced hypothyroidism. Thyroid. 2001 May;11(5):501-10. doi:10.1089/105072501300176462.

Laghi F, Adiguzel N, Tobin MJ. Endocrinological derangements in COPD. Eur Respir J. 2009 Oct;34(4):975-96. doi:10.1183/09031936.00103708.

Chaudhary SC, Ahmad T, Usman K, et al. Prevalence of thyroid dysfunction in chronic obstructive pulmonary disease patients in a tertiary care center in North India. J Family Med Prim Care. 2018 May-Jun;7(3):584-588. doi:10.4103/jfmpc.jfmpc_84_17.

Prakash R, Harish M, Suryanarayana V, Padma Priya M. Evaluation of thyroid functions in chronic obstructive pulmonary disease. World J Med Sci. 2014;11:57-8. doi:10.5829/idosi.wjms.2014.11.1.82110.

Korytina GF, Akhmadishina LZ, Kochetova OV, Aznabaeva YG, Zagidullin SZ, Victorova TV. Inflammatory and Immune Response Genes Polymorphisms are Associated with Susceptibility to Chronic Obstructive Pulmonary Disease in Tatars Population from Russia. Biochem Genet. 2016 Aug;54(4):388-412. doi:10.1007/s10528-016-9726-0.

Sanguinetti CM. N-acetylcysteine in COPD: why, how, and when? Multidiscip Respir Med. 2016 Feb 3;11:8. doi:10.1186/s40248-016-0039-2.

Agin Kh, Namavary J. A Survey on Thyroid Hormonal Status among Moderate to Severe Stable Chronic Obstructive Pulmonary Disease. Int J Med Toxicol Forensic Med. 2013;3(4):106-113. doi:10.22037/ijmtfm.v3i4(Autumn).3643.

Meral I, Arslan A, Him A, Arslan H. Smoking-related Alterations in Serum Levels of Thyroid Hormones and Insulin in Female and Male Students. Altern Ther Health Med. 2015 Sep-Oct;21(5):24-9.

Leach PT, Gould TJ. Thyroid hormone signaling: Contribution to neural function, cognition, and relationship to nicotine. Neurosci Biobehav Rev. 2015 Oct;57:252-63. doi:10.1016/j.neubiorev.2015.09.001.

Unnikrishnan AG, Kalra S, Sahay RK, Bantwal G, John M, Tewari N. Prevalence of hypothyroidism in adults: An epidemiological study in eight cities of India. Indian J Endocrinol Metab. 2013 Jul;17(4):647-52. doi:10.4103/2230-8210.113755.

Morganti S, Ceda GP, Saccani M, et al. Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrinol Invest. 2005;28(11 Suppl Proceedings):101-4.

Dimopoulou I, Ilias I, Mastorakos G, Mantzos E, Roussos C, Koutras DA. Effects of severity of chronic obstructive pulmonary disease on thyroid function. Metabolism. 2001 Dec;50(12):1397-401. doi:10.1053/meta.2001.28157.

Mortoglou A, Candiloros H. The serum triiodothyronine to thyroxine (T3/T4) ratio in various thyroid disorders and after Levothyroxine replacement therapy. Hormones (Athens). 2004 Apr-Jun;3(2):120-6. doi:10.14310/horm.2002.11120.

Bratel T, Wennlund A, Carlström K. Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of long-term oxygen treatment. Respir Med. 2000 Dec;94(12):1221-8. doi:10.1053/rmed.2000.0953.

Sarinc Ulasli S, Bozbas SS, Ozen ZE, Ozyurek BA, Ulubay G. Effect of thyroid function on COPD exacerbation frequency: a preliminary study. Multidiscip Respir Med. 2013 Oct 1;8(1):64. doi:10.1186/2049-6958-8-64.

Kostoglou-Athanassiou I, Ntalles K. Hypothyroidism - new aspects of an old disease. Hippokratia. 2010 Apr;14(2):82-7.

Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019 May 18;53(5):1900164. doi:10.1183/13993003.00164-2019.

Bacakoğlu F, Başoğlu OK, Gürgün A, Bayraktar F, Kiran B, Ozhan MH. Can impairments of thyroid function test affect prognosis in patients with respiratory failure? Tuberk Toraks. 2007;55(4):329-35.

Sadek SH, Khalifa WA, Azoz AM. Pulmonary consequences of hypothyroidism. Ann Thorac Med. 2017 Jul-Sep;12(3):204-208. doi: 10.4103/atm.ATM_364_16.

van Tuyl M, Blommaart PE, de Boer PA, et al. Prenatal exposure to thyroid hormone is necessary for normal postnatal development of murine heart and lungs. Dev Biol. 2004 Aug 1;272(1):104-17. doi:10.1016/j.ydbio.2004.03.042.

Ittermann T, Gläser S, Ewert R, Felix S, Völzke H, Dörr M. Serum thyroid-stimulating hormone levels are not associated with exercise capacity and lung function parameters in two population-based studies. BMC Pulm Med. 2014 Sep 2;14:145. doi:10.1186/1471-2466-14-145.

Simonides WS, van Hardeveld C. Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid. 2008 Feb;18(2):205-16. doi:10.1089/thy.2007.0256.

Khushu S, Rana P, Sekhri T, Sripathy G, Tripathi RP. Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study. Magn Reson Imaging. 2010 Jun;28(5):683-9. doi:10.1016/j.mri.2010.01.006.

Okamoto T, Kanazawa H, Hirata K, Yoshikawa J. Evaluation of oxygen uptake kinetics and oxygen kinetics of peripheral skeletal muscle during recovery from exercise in patients with chronic obstructive pulmonary disease. Clin Physiol Funct Imaging. 2003 Sep;23(5):257-62. doi:10.1046/j.1475-097x.2003.00500.x.

Iyer SK, Menon SK, Bahuleyan B. An Analysis of Dynamic Pulmonary Functions of Hypothyroid Patients. J Clin Diagn Res. 2017 Mar;11(3):CC10-CC12. doi:10.7860/JCDR/2017/24653.9579.

Koral L, Hekimsoy Z, Yildirim C, Ozmen B, Yorgancioglu A, Girgin A. Does thyroid replacement therapy affect pulmonary function tests in patients with subclinical hypothyroidism? Saudi Med J. 2006 Mar;27(3):329-32.

Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol. 2010 Apr;205(1):1-13. doi:10.1677/JOE-09-0412.

De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006 Jan;22(1):57-86, vi. doi:10.1016/j.ccc.2005.10.001.

Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014 Oct;24(10):1456-65. doi:10.1089/thy.2014.0201.

Langouche L, Jacobs A, Van den Berghe G. Nonthyroidal Illness Syndrome Across the Ages. J Endocr Soc. 2019 Oct 16;3(12):2313-2325. doi:10.1210/js.2019-00325.

Maiden MJ, Torpy DJ. Thyroid Hormones in Critical Illness. Crit Care Clin. 2019 Apr;35(2):375-388. doi:10.1016/j.ccc.2018.11.012.

El-Yazed HA, El-Bassiony MR, Eldaboosy SA, Gendi AE, Hashim M. Assessment of thyroid functions in patients with chronic obstructive pulmonary disease. Egyptian Journal of Chest Diseases and Tuberculosis. 2013;62(3):387-391. doi:10.1016/j.ejcdt.2013.07.009.

Gow SM, Seth J, Beckett GJ, Douglas G. Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive lung disease. Thorax. 1987 Jul;42(7):520-5. doi:10.1136/thx.42.7.520.

Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003 Nov;46:76s-80s. doi:10.1183/09031936.03.00004610.

Mancini A, Corbo GM, Gaballo A, et al. Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. Biofactors. 2005;25(1-4):201-4. doi:10.1002/biof.5520250124.

Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015 Oct;3(10):816-25. doi:10.1016/S2213-8587(15)00225-9.

van der Spek AH, Surovtseva OV, Jim KK, et al. Regulation of Intracellular Triiodothyronine Is Essential for Optimal Macrophage Function. Endocrinology. 2018 May 1;159(5):2241-2252. doi:10.1210/en.2018-00053.

Pashkovska NV. Pseudothyroid dysfunction in clinical practice: how to avoid diagnostic errors. Mìžnarodnij endokrinologìčnij žurnal. 2018;14(4):344-353. doi:10.22141/2224-0721.14.4.2018.140188. (in Ukrainian).

Yasar Z, Kirakli C, Cimen P, Ucar ZZ, Talay F, Tibet G. Is non-thyroidal illness syndrome a predictor for prolonged weaning in intubated chronic obstructive pulmonary disease patients? Int J Clin Exp Med. 2015 Jun 15;8(6):10114-21.

Montesinos MDM, Pellizas CG. Thyroid Hormone Action on Innate Immunity. Front Endocrinol (Lausanne). 2019 Jun 4;10:350. doi:10.3389/fendo.2019.00350.